Fate Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Fate Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fate Therapeutics Inc Strategy Report
- Understand Fate Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Fate Therapeutics Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Fate Therapeutics Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 09 Oct 2020 | Lorem |
| Fate’s multitargeted CAR NK carries potential to avoid antigen escape challenge; earlier intervention holds potential, experts say | 08 Oct 2020 | Manasi Vaidya |
| Innate Pharma recruits about 30 of 40 patients in second cohort of Phase Ib/II monalizumab trial in head and neck cancer, to close in the summer, source says | 04 Jun 2019 | Reynald Castaneda |
| Fate Therapeutics’ NK cell cancer immunotherapy NK100 yet to convince on early efficacy data; intraperitoneal route finds support for ovarian cancer while future combo likely, experts say | 16 Oct 2018 | Manasi Vaidya |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer